DK1613594T3 - 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere - Google Patents

4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere

Info

Publication number
DK1613594T3
DK1613594T3 DK04725299T DK04725299T DK1613594T3 DK 1613594 T3 DK1613594 T3 DK 1613594T3 DK 04725299 T DK04725299 T DK 04725299T DK 04725299 T DK04725299 T DK 04725299T DK 1613594 T3 DK1613594 T3 DK 1613594T3
Authority
DK
Denmark
Prior art keywords
phenylsulfanyl
phenyl
serotonin reuptake
reuptake inhibitors
tetrahydropyridine derivatives
Prior art date
Application number
DK04725299T
Other languages
Danish (da)
English (en)
Inventor
Benny Bang-Andersen
Karsten Juhl
Kim Andersen
Morten Jorgensen
Jan Kehler
Ask Pueschl
Thomas Ruhland
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1613594(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DK1613594T3 publication Critical patent/DK1613594T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
DK04725299T 2003-04-04 2004-04-02 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere DK1613594T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46026603P 2003-04-04 2003-04-04
DKPA200300518 2003-04-04
PCT/DK2004/000243 WO2004087662A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
DK1613594T3 true DK1613594T3 (da) 2008-07-14

Family

ID=35432910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04725299T DK1613594T3 (da) 2003-04-04 2004-04-02 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere

Country Status (28)

Country Link
US (1) US20070173522A1 (no)
EP (1) EP1613594B1 (no)
JP (1) JP2006522029A (no)
KR (1) KR20060021825A (no)
CN (1) CN100384822C (no)
AR (1) AR043964A1 (no)
AT (1) ATE390413T1 (no)
AU (1) AU2004226319A1 (no)
BR (1) BRPI0408453A (no)
CA (1) CA2521172A1 (no)
CL (1) CL2004000730A1 (no)
CO (1) CO5700777A2 (no)
DE (1) DE602004012724T2 (no)
DK (1) DK1613594T3 (no)
EA (1) EA009282B1 (no)
ES (1) ES2301979T3 (no)
HK (1) HK1090051A1 (no)
HR (1) HRP20080243T3 (no)
IS (1) IS8007A (no)
MX (1) MXPA05010678A (no)
NO (1) NO20055205L (no)
NZ (1) NZ541944A (no)
PL (1) PL1613594T3 (no)
PT (1) PT1613594E (no)
SI (1) SI1613594T1 (no)
UA (1) UA81300C2 (no)
WO (1) WO2004087662A1 (no)
ZA (1) ZA200507182B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732463B2 (en) 2003-04-04 2010-06-08 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
WO2007132841A1 (ja) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited 縮合複素環化合物およびその用途
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF
UA98698C2 (en) * 2008-03-03 2012-06-11 Х. Луннбек А/С Phenylsulfanylphenyl-piperidines and process for the preparation thereof
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
EP2930171A1 (en) * 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
DE2802306A1 (de) * 1977-01-27 1978-08-10 Hoechst Ag Azacycloalkane, azacycloalkene und ihre derivate
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
GB8912971D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
PL355289A1 (en) * 1999-10-13 2004-04-05 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
TR200201683T2 (tr) * 1999-12-30 2002-12-23 H. Lundbeck A/S İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
ZA200507182B (en) 2006-12-27
CA2521172A1 (en) 2004-10-14
ES2301979T3 (es) 2008-07-01
MXPA05010678A (es) 2005-12-12
AR043964A1 (es) 2005-08-17
CL2004000730A1 (es) 2005-02-18
HRP20080243T3 (en) 2009-04-30
ATE390413T1 (de) 2008-04-15
DE602004012724T2 (de) 2009-04-09
CN100384822C (zh) 2008-04-30
HK1090051A1 (en) 2006-12-15
UA81300C2 (en) 2007-12-25
BRPI0408453A (pt) 2006-04-04
NZ541944A (en) 2008-05-30
EP1613594A1 (en) 2006-01-11
PL1613594T3 (pl) 2008-09-30
CO5700777A2 (es) 2006-11-30
EA009282B1 (ru) 2007-12-28
US20070173522A1 (en) 2007-07-26
IS8007A (is) 2005-08-29
WO2004087662A1 (en) 2004-10-14
CN1777585A (zh) 2006-05-24
KR20060021825A (ko) 2006-03-08
EP1613594B1 (en) 2008-03-26
EA200501579A1 (ru) 2006-04-28
NO20055205L (no) 2005-11-04
DE602004012724D1 (de) 2008-05-08
SI1613594T1 (sl) 2008-08-31
AU2004226319A1 (en) 2004-10-14
JP2006522029A (ja) 2006-09-28
PT1613594E (pt) 2008-07-01

Similar Documents

Publication Publication Date Title
DK1749818T3 (da) Phenylpiperidinderivater som serotoningenoptagelseshæmmere
NO20034307D0 (no) Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK1658292T3 (da) Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer
HK1090051A1 (en) 4-(2-phenylsulfanyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
DK1959951T3 (da) Heteroaryl-substituerede piperidinderivater som L-CPT1-inhibitorer
ZA200410408B (en) N-substituted piperidine derivatives as serotonin receptor agents.
NO20053569D0 (no) Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister
DK1638933T3 (da) N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
NO20054607D0 (no) Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl
DK1711177T3 (da) 1H-thieno-2,3-c-pyrazolderivater, der er egnede som kinase-I-inhibitorer
NO20030842D0 (no) Fenoksybenzylamin-derivater som selektive serotonin- gjenopptaksinhibitorer
NO20041266L (no) Piperidinderivater som kan anvendes som CCR5-antagonister
DE602004010385D1 (de) 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate
NO20034525D0 (no) Fenyl heterocyklyleterderivater som serotonin re- opptaksinhibitorer
DK1176144T3 (da) Nye N-triazolylmethyl-piperazinderivater som neurokininreceptor-antagonister
IS7901A (is) 4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
IS7996A (is) 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar
IS8827A (is) 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSR).
DK1682523T3 (da) Morpholin-derivater som noradrenalin-genoptagelsesinhibitorer
DK1487802T3 (da) 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer
DK1377550T3 (da) Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer
NO20052192D0 (no) Substituerte 1,4-di-piperidin-4-yl-piperazinderivater og deres anvendelse som neurokininatagonister
ITMI20030636A1 (it) Metodo per la risoluzione di piperidine.